Singapore Medical Group's H1 profit surges to S$4m

SINGAPORE Medical Group's net profit for H1 2017 grew more than six times to S$4 million from the preceding year, the group said in a Singapore Exchange filing on Monday. This was spearheaded by its healthcare segment which increased 42.3 per cent year on year to S$21.9 million.

Another boost to its top-line growth was the group's Diagnostic & Aesthetics segment which increased 125.7 per cent year on year to S$8.6 million.

For the half-year ended June 30, revenue surged 57.5 per cent to S$30.7 million from S$19.5 million last year.

Earnings per share came in at 1.03 Singapore cents versus 0.23 Singapore cent a year ago.

No dividend was declared over the period, the same as the previous year.

The group's net asset value per ordinary share climbed to 20.07 Singapore cents as at June 30, from 7.49 Singapore cents six months ago.